胸腺肽联合新稀宝治疗小儿反复呼吸道感染疗效及免疫功能观察  

Observation of efficacy and immune function on Thymosin combined with Xinxibao in the treatment of children with recurrent respiratory tract infection

作　　者：焦会芳 王玉玲 

机构地区：[1]河南省洛阳市吉利区人民医院儿科,河南洛阳471012 [2]河南省洛阳市吉利区人民医院药剂科,河南洛阳471012

出　　处：《中国医药导报》2012年第7期59-60,63,共3页China Medical Herald

摘　　要：目的观察胸腺肽联合新稀宝对小儿反复呼吸道感染(RRI)的临床疗效及对免疫功能的影响。方法将110例RRI患儿分为治疗组(60例)和对照组(50例),两组均给予一般综合治疗,治疗组在一般治疗的基础上加用胸腺肽和新稀宝。结果治疗组疗效优于对照组(P<0.05),治疗后两组的免疫球蛋白(Ig)和T淋巴细胞亚群(CD)值都有所升高,两组比较差异有高度统计学意义(P<0.01)。结论胸腺肽联合新稀宝治疗小儿反复呼吸道感染疗效显著。Objective To observe the clinical curative effect and influence on immune function of Thymosin Combined with Xinxibao in children with recurrent respiratory tract infection（RRI）.Methods 110 cases of children with RRI were divided into treatment group（60 cases） and control group（50 cases）.Both groups were given the general comprehensive treatment,the treatment group was given Thymosin combined with Xinxibao on basis of general treatment.Results The curative effect in treatment group was superior to control group（P 〈 0.05）.After the treatment,Immune globulin（Ig） and T lymphocyte subsets（CD） of the two groups increased,the differences were statistically significant（P 〈 0.01）.Conclusion The effect of Thymosin combined with Xinxibao in the treatment of children with RRI is significant

关 键 词：胸腺肽 新稀宝 反复呼吸道感染 疗效 免疫功能 

分 类 号：R563.1[医药卫生—呼吸系统]